top of page

Email:  bd@sidmexinovia.com | Phone:  +918866862020

  • Whatsapp
  • Instagram
  • Facebook
  • X
  • LinkedIn

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Daclacure 30 mg Tablet

Daclacure 30 mg Tablet

Manufacturer/Marketed By : Emcure Pharmaceuticals Ltd

$45.33 $35.36

Daclacure 30 mg Tablet is a potent antiviral agent specifically designed to combat chronic hepatitis C, a liver infection caused by the hepatitis C virus in adults. This medication is...

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

Daclatasvir 30 mg

Active Pharmaceutical Ingredient

Daclacure 30 mg Tablet

SKU Emcure Pharmaceuticals Ltd
Precio original

45,33$

Precio de oferta

35,36$

Daclacure 30 mg Tablet is a potent antiviral agent specifically designed to combat chronic hepatitis C, a liver infection caused by the hepatitis C virus in adults. This medication is typically prescribed alongside other antiviral drugs, such as sofosbuvir, and may be used with or without ribavirin to enhance its efficacy. By working synergistically with these treatments, Daclacure effectively lowers the viral load in the body, promoting better liver health and improving overall outcomes. It is crucial for patients to follow their healthcare provider's instructions carefully while taking Daclacure, as improper use may lead to reduced effectiveness or the development of resistance. Patients should also be aware of potential side effects, which can range from mild to severe, and report any unusual symptoms to their doctor promptly. As with any antiviral therapy, regular monitoring and follow-up appointments are essential to ensure the treatment's success and address any concerns. Daclacure represents a significant advancement in the management of chronic hepatitis C, offering hope to those affected by this challenging condition. Always consult with your healthcare professional for personalized advice and information regarding your treatment plan.

Active Pharmaceutical Ingredient

Daclatasvir 30 mg

Uses

• Daclacure 30 mg tablet is primarily used for the treatment of chronic Hepatitis C infection. This medication is effective in managing the ongoing viral infection that can lead to significant liver damage over time. It works in conjunction with sofosbuvir, and may be used with or without ribavirin, to enhance treatment outcomes. Patients with chronic Hepatitis C can benefit from Daclacure 30 mg tablet as part of their therapeutic regimen.
• Individuals diagnosed with Hepatitis C Virus genotype 1 or genotype 3 can find Daclacure 30 mg tablet particularly beneficial. The tablet targets these specific genotypes, making it a suitable option for adult patients. By incorporating Daclacure 30 mg tablet into their treatment plan, patients may experience improved management of their condition. This targeted approach helps in reducing the viral load and promoting liver health.
• Daclacure 30 mg tablet is utilized in clinical settings to provide an effective solution for those suffering from chronic Hepatitis C. Its combination with sofosbuvir allows for a comprehensive approach to treatment. Healthcare providers often prescribe Daclacure 30 mg tablet to ensure patients receive a robust therapy aimed at clearing the virus. This medication is an important component of modern Hepatitis C management strategies.
• The use of Daclacure 30 mg tablet is integral in the treatment landscape for chronic Hepatitis C infections. It is designed to work effectively in adult patients, offering a reliable option for managing this viral infection. By following a treatment plan that includes Daclacure 30 mg tablet, patients may experience a more favorable response to their Hepatitis C management. This medication plays a crucial role in helping patients achieve better health outcomes.

Benefits

Daclacure 30 mg Tablet is effective in clearing the hepatitis C virus from the body in a high percentage of people. Daclacure 30 mg Tablet may cause a low risk of side effects compared to some older treatments for hepatitis C. Daclacure 30 mg Tablet does not have the same dietary restrictions as some older treatments for hepatitis C, which can make it easier for patients to stick to their treatment regimen.

Side Effects

Daclacure 30 mg Tablet may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.

Most Common Side Effects

• Nausea
• Tiredness
• Vomiting
• Headache

Common Side Effects

• Slower Rate of Heartbeat
• Liver Related Problems
• Body Pain
• Muscle Pain

How To Use

Daclacure 30 mg Tablet may take with or without food. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.

Safety Advice

• Alcohol: It is generally not recommended to drink alcohol while taking Daclacure 30 mg Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Daclacure 30 mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Daclacure 30 mg Tablet is recommended. If you experience any side effects please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Daclacure 30 mg Tablet. Daclacure 30 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Daclacure 30 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Daclacure 30 mg Tablet is safe to use in patients with liver disease. No dose adjustment of Daclacure 30 mg is recommended. If you experience any side effects please consult your doctor.
• Pregnancy: Use of Daclacure 30 mg Tablet may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Daclacure 30 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Daclacure 30 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Daclacure 30 mg.

Disclaimer

Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.

All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.

Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.

bottom of page